Determinants of rifabutin-associated uveitis in patients treated with rifabutin, clarithromycin, and ethambutol for Mycobacterium avium complex bacteremia: A multivariate analysis

Journal of Infectious Diseases

Volumn 177, Issue 1, 1998, Pages 252-255

  Shafran, Stephen D ^a   Singer, Joel ^b   Zarowny, Donald P ^b   Deschênes, Jean ^b   Phillips, Peter ^b   Turgeon, Fernand ^b   Aoki, Fred Y ^b   Toma, Emil ^b   Miller, Mark ^b   Duperval, Raymond ^b   Lemieux, Claude ^b   Schlech III, Walter F ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ETHAMBUTOL; FLUCONAZOLE; RIFABUTIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTEREMIA; BODY WEIGHT; FEMALE; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM AVIUM; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; UVEITIS;

EID: 17344366230     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517366     Document Type: Article

References (16)

1. Benson CA, Ellner JJ. Mycobacterium avium complex infection and AIDS: advances in theory and practice. Clin Infect Dis 1993;17:7-20.
2. USPHS/IDSA Prevention of Opportunistic Infections Working Group. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. Clin Infect Dis 1995;21:S32-43.
3. Nightingale SD, Cameron DW, Gordin FM, et al. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 1993;329:828-33.
4. Siegal FP, Eilbott D, Burger H, et al. Dose-limiting toxicity of rifabutin in AIDS-related complex: syndrome of arthralgia/arthritis. AIDS 1990; 4:433-41.
5. O'Brien RJ, Geiter LJ, Lyle MA. Rifabutin (ansamycin LM 427) for the treatment of pulmonary Mycobacterium avium complex. Am Rev Respir Dis 1990;141:821-6.
6. Hoy J, Mijch A, Sandland M, Grayson L, Lucas R, Dwyer B. Quadrupledrug therapy for Mycobacterium avium-intracellulare bacteremia in AIDS patients. J Infect Dis 1990;161:801-5.
7. Shafran SD, Deschênes J, Miller M, Phillips P, Toma E. Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. N Engl J Med 1994;330:438-9.
8. Shafran SD, Singer J, Zarowny DP, et al. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. N Engl J Med 1996;335:377-83.
9. Saran BR, Maguire AM, Nichols C, et al. Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin. Arch Ophthalmol 1994;112:1159-65.
10. Jacobs DS, Piliero PJ, Kuperwaser MG, et al. Acute uveitis associated with rifabutin use in patients with human immunodeficiency virus infection. Am J Ophthalmol 1994;118:716-22.
11. Wallace RJ Jr, Brown DA, Griffith DE, Girard W, Tanaka K. Reduced serum levels of clarithromycin in patients treated with multidrug regimens including rifampin or rifabutin for Mycobacterium avium-Myco-bacterium intracellulare infection. J Infect Dis 1995;171:747-50.
12. DATRI 001 Study Group. Clarithromyin (CL) plus rifabutin (RFB) for MAC prophylaxis: evidence for drug interaction [abstract]. In: Abstracts of the First National Conference on Human Retroviruses and Related Infections. Washington, DC: American Society for Microbiology, 1994.
13. DATRI 001 Study Group. Coadministration of clarithromycin (CL) alters the concentration-time profile of rifabutin (RFB) [abstract]. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando, FL). Washington, DC: American Society for Microbiology, 1994:3.
14. Trapnell CB, Narang PK, Li R, Lewis R, Colbom D, Lavelle J. Fluconazole (FLU) increases rifabutin (RIF) absorption in HIV(+) patients on stable zidovudine (ZDV) therapy [abstract]. In: Program and abstracts: IX International Conference on AIDS/IV STD World Congress (Berlin). London: Wellcome Foundation, 1993:504.
15. Narang PK, Trapnell CB, Schoenfelder JR, Lavelle JP, Bianchine JR. Fluconazole and enhanced effect of rifabutin prophylaxis [letter]. N Engl J Med 1994;330:1316.
16. Tseng AL, Walmsley SL. Rifabutin-associated uveitis. Ann Pharmacother 1995;29:1149-54.